Efficacy and safety of angiogenesis inhibitors in small-cell lung cancer

OBJECTIVE: The purpose of this study was to investigate the efficacy and safety of angiogenesis inhibitors for small-cell lung cancer (SCLC). METHODS: Totally, 16 controlled trials (1898 cases) involving angiogenesis inhibitors plus chemotherapy (ACT group) versus chemotherapy alone group (CT group)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lin, Heng, Li, Lina, Luo, Shuimei, Zhou, Sijing, Shen, Ruifen, Yang, Haitao, Chen, Huijuan, Xie, Xianhe
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352042/
https://ncbi.nlm.nih.gov/pubmed/27901478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados